Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals)

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) (USD $)
12 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Research and Development Expense [Member]
   
Non-cash stock option compensation expense   $ 233,233
Selling, General and Administrative Expenses [Member]
   
Non-cash stock option compensation expense $ 3,798,139 $ 492,032